Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 6—June 2007
Research

Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003

Judith E. Mueller*Comments to Author , Lassana Sangaré†, Berthe-Marie Njanpop-Lafourcade*, Zekiba Tarnagda‡, Yves Traoré§, Seydou Yaro¶, Raymond Borrow#, Bradford D. Gessner*, and Pierre Nicolas**
Author affiliations: *Agence de Médecine Préventive, Paris, France; †Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso; ‡Institut de Recherche en Science de la Santé, Bobo-Dioulasso, Burkina Faso; §Université de Ouagadougou, Ouagadougou, Burkina Faso; ¶Centre Muraz, Bobo-Dioulasso, Burkina Faso; #Health Protection Agency, Manchester, United Kingdom; **Institut de Médecine Tropicale du Service de Santé des Arnées, Marseille, France;

Main Article

Table 5

Overview of meningococci reported from meningitis patients in West Africa and the African meningitis belt, 2000–2005*

Sequence type (ST) Phenotype Place and time of meningococcal disease cases
ST-11 W135:2a:P1.5,2 Sporadic in Cameroon, Senegal, Burkina Faso, Central African Republic, Chad, Niger, and Ghana since 2003. Epidemic and major seasonal agent in Burkina Faso during 2002–2004 (including Bobo-Dioulasso)
W135:NT:P1.5,2 Sporadic in Bobo-Dioulasso, 2004
W135:2a:P1.2, W135:NT:P1.2 Sporadic in Niger, 2003
Y:14:P1.5,2 Sporadic in Bobo-Dioulasso, 2004
ST-1966 (ST-11 complex) W135:2a:P1.5,2 Sporadic in Burkina Faso
ST-2881 W135:NT:P1.5,2 Sporadic in Benin since 2003. Major seasonal agent in Niger during 2003
ST-5 A:4:P1.9, A:21:P1.9 Major seasonal agent in Niger, Senegal, and Burkina Faso during 2000–2001
ST-7 (ST-5 complex) A:4:P1.9, A:21:P1.9 Major seasonal agent and epidemic in Cameroon, Chad, Niger, Senegal, Benin, Burkina Faso, Ethiopia, and Nigeria
ST-2859 (ST-5 complex) A:4:P1.9, A:21:P1.9 Major seasonal agent and epidemic in Burkina Faso since 2003 (including Bobo-Dioulasso)
ST-751 X:NT:P1.5, X:NT:P1.5,2 Sporadic in Burkina Faso (including Bobo-Dioulasso), Niger, and Ghana
ST-181 X:NT:P1.5 Sporadic in Niger
ST-2880 Y:14:P1.5,2 Sporadic in Niger
ST-4375 (ST-23 complex) Polyagglutinable:14:P1.5,2 Sporadic in Bobo-Dioulasso, 2004
W135:NT:P1.5,2 Sporadic in Bobo-Dioulasso, 2004
ST-23 (ST-23 complex) Y:14:NST Sporadic in Senegal
ST-32, ST-2496 (ST-32 complex), ST-291 (ST-41/44 complex) C:4:P1.16, B:4:P1.16, B:4:P1.7,16, B:4:P1.9 Sporadic in Cameroon
ST-192
 NG:NT:NST
 Sporadic in Bobo-Dioulasso, 2003 and 2004
*Data were obtained from references 1,5,16,17,20–22, and the Neisseria multilocus sequencing typing website (http://pubmlst.org/ neisseria).

Main Article

References
  1. Nicolas  P, Norheim  G, Garnotel  E, Djibo  S, Caugant  DA. Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol. 2005;43:5129–35. DOIPubMedGoogle Scholar
  2. Kwara  A, Adegbola  RA, Corrah  PT, Weber  M, Achtman  M, Morelli  G, Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health. 1998;3:742–6.PubMedGoogle Scholar
  3. Taha  MK, Parent du Chatelet  I, Schlumberger  M, Sanou  I, Djibo  S, de Chabalier  F, Neisseria meningitidis serogroups S135 and A were equally prevalent among meningitis cases occurring at the end of 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol. 2002;40:1083–4. DOIPubMedGoogle Scholar
  4. World Health Organization. Meningococcal disease, serogroup W135, Burkina Faso. Wkly Epidemiol Rec. 2002;77:152–5.PubMedGoogle Scholar
  5. Traoré  Y, Njanpop-Lafourcade  BM, Adjogble  KLS, Lourd  M, Yaro  S, Nacro  B, The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002–5. Clin Infect Dis. 2006;43:817–22. DOIPubMedGoogle Scholar
  6. World Health Organization. Meningococcal disease, African meningitis belt, epidemic season 2006. Wkly Epidemiol Rec. 2006;81:119–20.PubMedGoogle Scholar
  7. Mueller  JE, Yaro  S, Traoré  Y, Sangaré  L, Tarnagda  Z, Njanpop-Lafourcade  BM, Neisseria meningitidis: carriage and immunity in Burkina Faso, 2003. J Infect Dis. 2006;193:812–20. DOIPubMedGoogle Scholar
  8. World Health Organization. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO communicable disease surveillance and response. WHO/CDS/CSR/EDC/99.7. Geneva: The Organization; 1999.
  9. Taha  MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol. 2000;38:855–7.PubMedGoogle Scholar
  10. Deghmane  AE, Giogini  D, Larribe  M, Alonso  JM, Taha  MK. Down regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by crgA regulatory protein. Mol Microbiol. 2002;43:1555–64. DOIPubMedGoogle Scholar
  11. Poolman  JT, Abdillahi  H. Outer membrane protein serosubtyping of Neisseria meningitidis. Eur J Clin Microbiol Infect Dis. 1988;7:291–2. DOIPubMedGoogle Scholar
  12. Nicolas  P, Parzy  D, Martet  G. Pulsed-field gel electrophoresis analysis of clonal relationships among Neisseria meningitidis A strains from different outbreaks. Eur J Clin Microbiol Infect Dis. 1997;16:541–4. DOIPubMedGoogle Scholar
  13. Tenover  FC, Arbeit  RD, Goering  RV, Mickelsen  PA, Murray  BE, Persing  DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMedGoogle Scholar
  14. Maiden  MC, Bygraves  JA, Feil  E, Morelli  G, Russell  JE, Urwin  R, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:3140–5. DOIPubMedGoogle Scholar
  15. de Wals  P, Bouckaert  A. Methods for estimating the duration of bacterial carriage. Int J Epidemiol. 1985;14:628–34. DOIPubMedGoogle Scholar
  16. Nicolas  P, Djibo  S, Moussa  A, Tenebray  B, Boisier  P, Chanteau  S. Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains. J Clin Microbiol. 2005;43:1437–8. DOIPubMedGoogle Scholar
  17. Parent du Châtelet  I, Traore  Y, Gessner  BD, Antignac  A, Naccro  B, Njanpop-Lafourcade  BM, Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis. 2005;40:17–25. DOIPubMedGoogle Scholar
  18. Amadou Hamidou  A, Djibo  S, Elhaj Mahamane  A, Moussa  A, Findlow  H, Sidikou  F, Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135. Microbes Infect. 2006;8:2098–104. DOIPubMedGoogle Scholar
  19. Balmer  P, Borrow  R, Miller  E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol. 2002;51:717–22.PubMedGoogle Scholar
  20. Forgor  AA, Leimkugel  J, Hodgson  A, Bugri  A, Dangy  JP, Gagneux  S, Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health. 2005;10:1229–34. DOIPubMedGoogle Scholar
  21. Njanpop-Lafourcade  BM, Parent du Chatelet  I, Sanou  O, Alonso  JM, Taha  MK. The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates. Microbes Infect. 2005;7:645–9.PubMedGoogle Scholar
  22. Ouedraogo-Traoré  R, Høiby  EA, Sanou  I, Sangare  L, Kyelem  N, Ye-Ouattara  D, Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001. Scand J Infect Dis. 2002;34:804–7. DOIPubMedGoogle Scholar
  23. Swartley  JS, Marfin  AA, Edupuganti  S, Liu  LJ, Cieslak  P, Perkins  B, Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A. 1997;94:271–6. DOIPubMedGoogle Scholar
  24. Raghunathan  PL, Jones  JD, Tiendrebeogo  SR, Sanou  I, Sangaré  L, Kouanda  S, Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. J Infect Dis. 2006;193:607–16. DOIPubMedGoogle Scholar
  25. Blakebrough  IS, Greenwood  BM, Whittle  HC, Bradley  AK, Gilles  HM. The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis. 1982;146:626–37.PubMedGoogle Scholar
  26. Gagneux  SP, Hodgson  A, Smith  TA, Wirth  T, Erhard  I, Morelli  G, Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis. 2002;185:618–26. DOIPubMedGoogle Scholar
  27. Taha  MK, Giorgini  D, Ducos-Galand  M, Alonso  JM. Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol. 2004;42:4158–63. DOIPubMedGoogle Scholar
  28. Yazdankhah  SP, Kriz  P, Tzanakaki  G, Kremastinou  J, Kalmusova  J, Musilek  M, Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol. 2004;42:5146–53. DOIPubMedGoogle Scholar
  29. Maiden  MC, Stuart  JM; UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 2002;359:1829–31. DOIPubMedGoogle Scholar
  30. Ala’Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol. 2000;38:2311–6.PubMedGoogle Scholar
  31. Balkhy  HH, Memish  ZA, Almuneef  MA, Osoba  AO. Neisseria meningitidis W-135 carriage during the Hajj season 2003. Scand J Infect Dis. 2004;36:264–8. DOIPubMedGoogle Scholar
  32. Fijen  CA, Kuijper  EJ, Tjia  HG, Daha  MR, Dankert  J. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis. 1994;18:780–4.PubMedGoogle Scholar
  33. Findlow  H, Vogel  U, Mueller  JE, Curry  A, Njanpop-Lafourcade  BM, Claus  H, Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. J Infect Dis. 2007;195:1071–7. DOIPubMedGoogle Scholar
  34. Yazdankhah  SP, Caugant  DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53:821–32. DOIPubMedGoogle Scholar
  35. Riordan  T, Cartwright  KAV, Andrews  N, Stuart  J, Burris  A, Fox  A, Acquisition and carriage of meningococci in marine commando recruits. Epidemiol Infect. 1998;121:495–505. DOIPubMedGoogle Scholar

Main Article

Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external